Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
FOMX was delisted on the 6th of March, 2020.
84 hedge funds and large institutions have $164M invested in Foamix Pharmaceuticals Ltd. Ordinary Shares in 2015 Q2 according to their latest regulatory filings, with 58 funds opening new positions, 18 increasing their positions, 5 reducing their positions, and 4 closing their positions.
1,350% more first-time investments, than exits
New positions opened: 58 | Existing positions closed: 4
260% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 5
171% more funds holding
Funds holding: 31 → 84 (+53)
139% more capital invested
Capital invested by funds: $68.7M → $164M (+$95.3M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
+$17.3M |
| 2 |
VAM
Visium Asset Management
New York
|
+$8.55M |
| 3 |
MMH
Menora Mivtachim Holdings
Ramat Gan,
Israel
|
+$8.03M |
| 4 |
Bank of New York Mellon
New York
|
+$7.25M |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$6.34M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jennison Associates
New York
|
-$10.1M |
| 2 |
PCM
Pentwater Capital Management
Naples,
Florida
|
-$5.31M |
| 3 |
FAM
Fred Alger Management
New York
|
-$634K |
| 4 |
Millennium Management
New York
|
-$332K |
| 5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$230K |
FOMX Hedge Fund Activity: Q2 2015 in Review
84 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) for Q2 2015, worth a combined $164M — up 139% from $68.7M a quarter earlier.
Buyers outnumbered sellers: 58 funds opened new FOMX positions and 4 closed out — a net gain of 54 holders — while 18 added to existing stakes and 5 trimmed.
The largest buyer was Franklin Resources, opening a new position worth an estimated $17.3M. The largest seller was Jennison Associates, exiting entirely with an estimated $10.1M sold.
- 84 institutional investors held Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) as of Q2 2015, up from 31 in Q1 2015.
- Funds reported $164M of Foamix Pharmaceuticals Ltd. Ordinary Shares stock for Q2 2015, up 139% quarter-over-quarter.
- 58 funds opened new Foamix Pharmaceuticals Ltd. Ordinary Shares positions in Q2 2015 and 4 closed out, a net change of +54 holders.
- The largest Foamix Pharmaceuticals Ltd. Ordinary Shares buyer in Q2 2015 was Franklin Resources, an estimated $17.3M added.
- The largest Foamix Pharmaceuticals Ltd. Ordinary Shares seller in Q2 2015 was Jennison Associates, an estimated $10.1M sold.
Based on aggregated 13F filings for Q2 2015.